During the past decade, Massachusetts General Hospital, Neurology Clinical Trials Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Massachusetts General Hospital, Neurology Clinical Trials Unit" #1 collaborator was "Massachusetts General Hospital" with 1 trials as a collaborator, "North East Amyotrophic Lateral Sclerosis Consortium" with 1 trials as a collaborator and "The Center for Clinical and Translational Sciences (CCTS) Clinical Research Unit at The University of Texas Health Science Center at Houston" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Massachusetts General Hospital, Neurology Clinical Trials Unit" are "Amyotrophic Lateral Sclerosis" (2 trials), "ALS" (1 trials) and "ALS (Amyotrophic Lateral Sclerosis)" (1 trials). Many other conditions were trialed in "Massachusetts General Hospital, Neurology Clinical Trials Unit" in a lesser frequency.

Most popular intervention types in "Massachusetts General Hospital, Neurology Clinical Trials Unit" are "Drug" (3 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "CK-2017357" (1 trials), "Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections" (1 trials), "Monthly placebo infusions + 3 times per week placebo injections" (1 trials) and "Reldesemtiv" (1 trials). Other intervention names were less common.

The vast majority of trials in "Massachusetts General Hospital, Neurology Clinical Trials Unit" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Massachusetts General Hospital, Neurology Clinical Trials Unit". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Massachusetts General Hospital, Neurology Clinical Trials Unit, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Massachusetts General Hospital, Neurology Clinical Trials Unit, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".